Singapore: Asia Pacific market for transcatheter embolization and occlusion (TEO) devices in countries including Austral...
Singapore: Brisbane-based R&D company Alchemia has recruited the 390th patient for the pivotal phase III clinical tr...
Singapore: Global Non-Small Cell Lung Cancer (NSCLC) treatment market value will increase from USD5.1 billion in 2013 to...
Singapore: In the battle against Ebola, incentives from government and healthcare policymakers have been vital for advan...
Singapore: Australia-based Telstra Health has acquired India-based health software solutions provider, IdeaObject Softwa...
Singapore: Australia-based bioCSL has joined forces with New Zealand-based ALK to commercialize three ALK allergy immuno...
Singapore: A latest research conducted by the New University of Adelaide has established the reason why dieters tend to ...
Singapore: Western Allergy, the 42-year-old vaccine firm, has announced the expansion of its business into Australia. Th...
Singapore: Australia-based Benitec biopharma has acquired the full rights to the pre-clinical ddRNAi-based hepatitis B (...
Singapore: Australia-based drug giant, Mayne pharma has reportedly filed an application seeking rights to produce and ma...
Singapore: After a recent inspection of Hospira's Melbourne based facility, FDA has labelled the pharma giant's drugs as...
Singapore: The US-based Novavax recently announced that it has begun human trials for its Ebola vaccine shot. The devel...
As per the estimates, currently, there are more than 36 million people living with dementia worldwide. Further, it is ...
Singapore: Algae.Tec, an advanced algae to biofuels company, has opened a new facility Shoalhaven One at Nowra, south of...
Singapore: Australia-based Prima BioMed has announced the acquisition of France-based Immutep, a private biopharmaceutic...
Singapore: Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from $1.9 bil...
Singapore: Patrys received approval to progress its phase I/IIa PAT-SM6 multiple myeloma trial based on safety data from...
Singapore: The global private equity firm, Riverside Company has said that it would be investing about $100 million in A...
